In addition, a joint study recruiting 97 tumor specimens from Japanese lung cancer patients with EGFR-mutation reported that HGF overexpression was detected more frequently than other factors (T790 M and MET amplification) in both 23 tumors with acquired resistance (61%) and 45 tumors with intrinsic resistance (29%) [36]. The gene discussed is EGFR; the disease is lung cancer.